Cercar
01/12/2022
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
Martin-Varillas, JL, Sanchez-Bilbao, L, Calvo-Rio, V, Adan, A, Hernanz, I, Gallego-Flores, A, Beltran-Catalan, E, Castro-Oreiro, S, Fanlo, P, Martos, AG, Torre, I, Cordero-Coma, M, De Dios, JR, Garcia-Aparicio, A, Hernandez-Garfella, M, Sanchez-Andrade, A, Garcia-Valle, A, Maiz, O, Miguelez, R, Rodriguez-Montero, S, Urruticoechea, A, Veroz, R, Conesa, A, Fernandez-Carballido, C, Jovani, V, Mondejar, JJ, Gonzalez, OM, Alvarado, PM, Romero-Yuste, S, Rubio-Munoz, P, Pena-Sainz-Pardo, E, Garijo-Bufort, M, Demetrio-Pablo, R, Hernandez, JL, Blanco, R. Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients. RMD Open. 2022; 8(2)DOI:10.1136/rmdopen-2022-002693. PMID:36597972. IF:6.200(Q1/2D).
17/10/2022
Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren's syndrome: A critical review
Vilchez-Oya, F, Martin, HB, Garcia-Martinez, E, Corominas, H. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren's syndrome: A critical review. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.1003054. PMID:36325321. IF:7.300(Q1/3D).
01/08/2022
Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data
Hemmig, AK, Gozzoli, D, Werlen, L, Ewald, H, Aschwanden, M, Blockmans, D, Brouwer, E, Buchanan, RRC, Camellino, D, Campochiaro, C, Cimmino, MA, Corominas, H, Gloy, V, Henckaerts, L, Kyburz, D, Moya-Alvarado, P, Owen, CE, Stegert, M, Tomelleri, A, van Sleen, Y, Yamashita, H, Imfeld, S, Berger, CT, Hemkens, LG, Daikeler, T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 55DOI:10.1016/j.semarthrit.2022.152017. PMID:35537222. IF:5.000(Q2/3D).
01/08/2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases
Zozaya N., Arrizubieta Basterrechea M.I., Bollo E., Castellví I., Espín J., Ortego N., Poveda-Andrés J.L., Rodríguez Portal J.A., Rivero A., Marcos-Rodríguez J.A., Verde L.. A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE. 2022; 38(1)DOI:10.1017/S0266462322000459. PMID:35912833. IF:3.200(Q2/5D).
08/07/2022
Continuing medical education. An opportunity to continue improving
Calvo, JIP, Pou, JCI. Continuing medical education. An opportunity to continue improving. MEDICINA CLINICA. 2022; 159(1)DOI:10.1016/j.medcli.2022.03.012. PMID:35636993. IF:3.900(Q2/4D).
01/01/2022
Characteristics associated with the perception of high-impact disease (PsAID =4) in patients with recent-onset psoriatic arthritis. Machine learning-based model
Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Baute J.J.B., Ibáñez B.J., Toniolo E., Ramírez J., García A.S.. Characteristics associated with the perception of high-impact disease (PsAID =4) in patients with recent-onset psoriatic arthritis. Machine learning-based model. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022; 57DOI:10.1016/j.semarthrit.2022.152097. PMID:36113222. IF:5.000(Q2/3D).
01/01/2022
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
Kerick M., Acosta-Herrera M., Simeón-Aznar C.P., Callejas J.L., Assassi S., Carreira P., Castellvi I., Ríos R., Portales R.G., Fernández-Nebro A., García-Hernández F.J., Aguirre M.A., Fernández-Gutiérrez B., Rodríguez-Rodríguez L., de la Peña P.G., Vicente E., Andreu J.L., de Castro M.F., López-Longo F.J., Fonollosa V., Guillén A., Tolosa C., Pros A., Beltrán E., Carballeira M.R., Narváez F.J., Rivas M.R., Ortiz-Santamaría V., Madroñero A.B., González-Gay M.A., Díaz B., Trapiella L., Egurbide M.V., Fanlo-Mateo P., Saez-Comet L., Díaz F., Roman-Ivorra J.A., Sancho J.J.A., Freire M., Garcia F.J.B., Oreiro N., Kreuter A., Riemekasten G., Airò P., Magro C., Voskuyl A.E., Vonk M.C., Hesselstrand R., Nordin A., Lunardi C., Gabrielli A., Hoffmann-Vold A., Distler J.H.W., Padyukov L., Koeleman B.P.C., Proudman S.M., Nikpour M., Stevens W., Zochling J., Sahhar J., Roddy J., Nash P., Tymms K., Rischmueller M., Lester S., Vigone B., Pers J.-O., Saraux A., Devauchelle-Pensec V., Cornec D., Jousse-Joulin S., Lauwerys B., Ducreux J., Maudoux A.-L., Vasconcelos C., Tavares A., Neves E., Faria R., Brandão M., Campar A., Marinho A., Farinha F., Almeida I., Mantecón M.A.G.-G., Alonso R.B., Martínez A.C., Cervera R., Rodríguez-Pintó I., Espinosa G., Lories R., De Langhe E., Belz D., Witte T., Baerlecken N., Stummvoll G., Zauner M., Lehner M., Collantes E., Ortega-Castro R., Aguirre-Zamorano M.A., Escudero-Contreras A., Castro-Villegas M.C., Roldán M.C.F., Ortego N., Raya E., Moleón I.J., de Ramon E., Quintero I.D., Meroni P.L., Gerosa M., Schioppo T., Artusi C., Chizzolini C., Zuber A., Wynar D., Kovács L., Balog A., Deák M., Bocskai M., Dulic S., Kádár G., Hiepe F., Gerl V., Thiel S., Maresca M.R., López-Berrio A., Aguilar-Quesada R., Navarro-Linares H., Hunzelmann N., Moroncini G., de Vries-Bouwstra J.K., Orozco G., Barton A., Herrick A.L., Terao C., Allanore Y., Fonseca C., Alarcón-Riquelme M.E., Radstake T.R.D.J., Beretta L., Denton C.P., Mayes M.D., Martin J.. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis. npj Genomic Medicine. 2022; 7(1)DOI:10.1038/s41525-022-00327-8. PMID:36198672. IF:5.300(Q1/2D).
01/01/2022
Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning
Queiro R., Seoane-Mato D., Laiz A., Agirregoikoa E.G., Montilla C., Park H.-S., Pinto-Tasende J.A., Bethencourt Baute J.J., Ibáñez B.J., Toniolo E., Ramírez J., García A.S., Cañete J.D., Juanola X., Fiter J., Gratacós J., Rodriguez-Moreno J., Rosa J.N., Martín A.L., García A.B., Segura P.C., Ferrer A.L., Barrio S.P., Plata Izquierdo A.J., Bustabad S., Guimerá Martín-Neda F.J., Capdevilla E.F., Díaz R.R., Cuervo A., Gibert M.A., Larraz P.T., de la Morena Barrio I., Lanza L.P., Sanchís D.B., Mesquida C.M., Murillo C., Moreno Ramos M.J., Beteta M.D., Guillén P.S.-P., Oliveira L.L., Marco T.N., Cebrián L., de la Cueva Dobao P., Steiner M., Muñoz-Fernández S., Garrido R.V., León M., Rubio E., Jiménez A.M., Fernández-Freire L.R., Luezas J.M., Sánchez-González M.D., Muñoz C.S., Senabre J.M., Rosas J.C., Soler G.S., Mataix Díaz F.J., Nieto-González J.C., González C., Ovalles Bonilla J.G., Rodríguez O.B., Medina F.J.N., Luján D., Ruiz Montesino M.D., Carrizosa Esquivel A.M., Fernández-Carballido C., Martínez-Vidal M.P., Fernández L.G., Jovani V., Alameda R.C., Sabater S.G., Romero I.B., Urruticoechea-Arana A., Torres M.S., Almodóvar R., López Estebaranz J.L., López Montilla M.D., García-Nieto A.V.. Minimal disease activity (MDA) in patients with recent-onset psoriatic arthritis: predictive model based on machine learning. ARTHRITIS RESEARCH & THERAPY. 2022; 24(1)DOI:10.1186/s13075-022-02838-2. PMID:35751091. IF:4.900(Q2/4D).